Previously, we reported that when the cytotoxic effects of 4Ј-O-alkylaloenin derivatives (from methyl to hexadecyl) derived from aloenin (1) are compared, the longer the alkyl chain of the 4Ј-O-alkylaloenin derivatives, the greater is the enhancement in the cytotoxic effects on human colorectal (HCT 116) and human hepatoma (Hep G2) cancer cell lines.
Previously, we reported that when the cytotoxic effects of 4Ј-O-alkylaloenin derivatives (from methyl to hexadecyl) derived from aloenin (1) are compared, the longer the alkyl chain of the 4Ј-O-alkylaloenin derivatives, the greater is the enhancement in the cytotoxic effects on human colorectal (HCT 116) and human hepatoma (Hep G2) cancer cell lines.
1) Furthermore, we reported that pseudodiosgenone derivatives having various amino groups, thiocyano (SCN), and selenocyano (SeCN) groups at the 26 position derived from diosgenin (2) exhibited the potent cytotoxic activities against the same cancer cell lines, 2) while compounds 1 and 2 have not been known to exhibit cytotoxic activity yet. In our preliminary investigation, these compounds also showed no marked cytotoxicity in less than 500 mM of the IC 50 valuethe concentration at which 50% of the cells are inhibited from growing. However, from the both above-mentioned reports, it is evident that a compound that possessed an alkyl chain with an appropriate length or that introduced appropriate substituents such as amino, thiocyano, and selecocyano groups in the molecule seemed to exhibit potent cytotoxic activity.
In the present study, we investigate the preparation of 1,8-di-O-alkylaloe-emodins and 15-amino-, 15-thiocyano-, and 15-selenocyanochrysophanol derivatives from aloe-emodin (3) which has been known to have several pharmacological activities such as cytotoxic activity, [3] [4] [5] antifungal activity, 6) antibacterial activity, 7) and so on, and further we evaluate the cytotoxic effects of the synthetic derivatives on HCT 116 and Hep G2 cancer cell lines.
Results and Discussion
Aloe-emodin 3 is an anthraquinone derivative isolated from many Chinese herbal medicines such as Aloe arborensces MILL. var. natalensis BERGER (Liliaceae), 8, 9) Rheum palumatum L. (Poligonaceae), 10, 11) Cassia tora L. (Leguminosae), 12) and so on. This anthraquinone derivative has two phenolic hydroxyl groups at the 1 and 8 positions and one aliphatic hydroxyl group at the 15 position. In this study, the alkylations of the phenolic hydroxyl groups and the substitution reactions with various amino groups and thiocyano and selenocyano groups at the 15 position of 3 were performed to compare their cytotoxic activities. First, several alkyl derivatives were prepared from 3. The methylation of 3 with dimethylsulfate in the presence of K 2 CO 3 was done according to the method reported by Ross and Mitali. 13) to give 1,8-di-O-methylaloe-emodin 4 in a 61.6% yield. Other alkylations were performed according to the method of MacTough et al. 14) Compound 3 was reacted with propyl iodide, hexyl bromide, dodecyl iodide, and octadecyl iodide in the presence of K 2 CO 3 yields, respectively.
The cytotoxic effects of alkylaloe-emodin derivatives were tested by performing the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 15) using human colorectal (HCT 116) 16) and human hepatoma (Hep G2) 17) cancer cell lines, and the effects were represented by IC 50 values-the concentrations at which 50% of the cells are inhibited from growing. The former expresses very little MDR 1 (P-glycoprotein; P-gp), while the latter overexpresses Pgp. 17) It has been known that P-gp acts as an efflux pump to remove several antitumor agents such as Ca 2ϩ antagonist, cyclosporine, and dioxin from P-gp-overexpressing cells. 18) Among alkylaloe-emodins 4-8, only 1,8-di-O-hexylaloeemodisn 6 showed an almost similar effect (IC 50 value: 9.7Ϯ3.5 mM) on HCT 116 cells as compared to that of aloeemodin 3 (IC 50 value: 8.7Ϯ0.8 mM) ( Table 1 ). The activities of 1,8-O-dimethyl-4 and 1,8-O-dipropylaloe-emodin 5 (IC 50 values: 40.8Ϯ5.7 and 46.9Ϯ4.3 mM, respectively), which had shorter alkyl chains than that of 6, decreased. These results suggest that there is no relationship between the cytotoxic activity and the alkyl chain lengths of alkylaloe-emodin derivatives against HCT 116 cells. Although it was difficult to determine the exact IC 50 values for 1,8-di-O-dodecyl-7 and 1,8-di-O-octadecylaloe-emodin 8 (because of the turbidity in the concentrations that were used to determine the IC 50 value), they showed no marked activities. In the case of Hep G2 cells, only 3 showed potent activity (IC 50 value: 10.0Ϯ0.9 mM) which was almost similar to the value of 3 in the case of HCT 116 cells, while all alkylated aloe-emodins 4-8 showed no marked activity. This result indicates that aloe-emodin derivatives introducing alkyl groups at the 1 and 8 positions may be influenced by the efflux pump of P-gp in Hep G2 cells.
Next, the hydroxyl group at the 15 position of aloe-emodin 3 and 1,8-di-O-hexylaloe-emodin 6, which showed potent cytotoxic activities against HCT 116 cells, was replaced with amino groups and thiocyano (SCN) and selenocyano (SeCN) groups, and the cytotoxic activities of the products were further evaluated. The treatment of 3 with CBr 4 and PPh 3 in tetra hydro fran (THF) gave bromide 9 in 81.9% yields, which was used as the starting material for the introduction of various amino groups at the 15 position of 3. Compound 9 was reacted with diethylamine, pyrrolidine, piperidine, 1-methylpiperazine and imidazole according to the method of Quan et al. 19) to give compounds 10-14 (in 48.3, 58.0, 28.6, 33.7, 19.3% yields, respectively). In the preparation of amino derivatives from 1,8-di-O-hexylaloe-emodin 6, iodide 15 was used as the starting material in order to increase the yield. Compound 15 was derived from 6 as follows: the tosylation 20) of 6 gave tosylate 16 that reacted with sodium iodide to give 15. The reaction of 15 with diethylamine, pyrrolidine, piperidine, 1-methylpiperazine, and imidazole gave 17-21 (in 58.0, 62.0, 52.0, 48.3, 66.5% yields, respectively).
Next, the hydroxyl group at the 15 position of compounds 3 and 6 was replaced with thiocyano (SCN) and selenocyano (SeCN) groups. The reaction of bromide 9 with KSCN and 
Conclusions
In The replacement of the hydroxyl group at the 15 position of 3 and 6 with SCN and SeCN groups also enhanced the cytotoxic effects (Table 3 ). In the case of Hep G2 cells, selenocyano derivatives 23 (IC 50 value: 5.9Ϯ0.9 mM) and 26 (IC 50 value: 0.7Ϯ0.1 mM) showed higher potent effect on stably Pgp-expressing Hep G2 cells than corresponding thiocyano derivatives 22 (IC 50 value: 22.5Ϯ3.1 mM) and 25 (IC 50 value: 7.6Ϯ0.8 mM), respectively. Although the exact structure-activity relationship for the affinity to enzymes, intracellular accumulation, and so on has not been resolved yet, these derivatives may help to overcome drug excretion from stably P-gp-expressing cancer cells caused by multidrug resistance without any modulator.
Experimental
General Methods Reagent-grade chemicals and solvents were obtained from commercial suppliers. The melting points (mp) were determined using a Yanagimoto micromelting point apparatus and were uncorrected. Kieselgel 60 F 254 (E. Merck) was used in thin-layer chromatography (TLC). Spots were detected by spraying plates with 1 : 9 Ce(SO 4 ) 2 -10% H 2 SO 4 reagent, followed by heating the plates at 250°C for 4-5 min. Preparative TLC was performed using silica gel 60 F 254 (Merck, 200ϫ200ϫ2 mm). Column chromatography was carried out using Kieselgel 60 (E. Merck), then the eluates were monitored by TLC. An SSC-6300 HPLC instrument (Senshu Co., Ltd.) was employed for analytical HPLC using column DOCOSIL (Senshu Co., Ltd.; 10ϫ250 mm) attached to an SSC autoinjector 6310 and an SSC fraction collector 6320 for preparative HPLC. , dd (doublet of doublets), t (triplet), q (quartet), quin (quintet), and m (multiplet). Electron impact mass spectrum (EI-MS) and fast-atom-bombardment mass spectrum (FAB-MS) were recorded using a JEOL JMS-DX 300 mass spectrometer. The high-resolution mass (HR-MS) spectra were recorded using JEOL JMS-700.
1,8-Di-O-methylaloe-emodin (4)
A solution of 3 (100 mg, 0.37 mmol) in dry acetone (10 ml) was added with dimethylsulfate (230 mg, 1.8 mmol) and absolute K 2 CO 3 (250 mg, 1.8 mmol), and then refluxed overnight. The reaction mixture was added with more dimethylsulfate (230 mg, 1.8 mmol) and absolute K 2 CO 3 (250 mg, 1.8 mmol) and refluxed for 12 h. The mixture was poured into ice-cold water (50 ml) and extracted with AcOEt (50 mlϫ3). The AcOEt extracts were successively washed with brine and water, dried over absolute Na 2 SO 4 , and then filtered. The filtrate was evaporated to give a residue that was subjected to column chromatography (a gradient of 0-5% AcOEt in hexane), followed by preparative HPLC (solvent system: 55% H 2 O in acetone, flow rate of 1.0 ml/min, and column temperature of 40°C) to obtain 4 (68.2 mg, 61.6%) as yellow needles, mp 223-226°C (after recrystallization from acetone 
1,8-Di-O-propylaloe-emodin (5)
To a solution of 3 (100 mg, 0.37 mmol) in absolute DMF (10 ml), propyl iodide (460 mg, 2.7 mmol) and absolute K 2 CO 3 (260 mg, 1.9 mmol) were added, and then the mixture was refluxed overnight. The reaction mixture was extracted with AcOEt (50 mlϫ3). The organic extracts were successively washed with 5% HCl, 10% NaHCO 3 and water, dried over absolute MgSO 4 , and then filtered. The filtrates were evaporated to give a residue that was subjected to column chromatography (a gradient of 0-5% AcOEt in hexane), followed by preparative HPLC (column: DOCOSIL 10ϫ250 mm, solvent: 50% H 2 O in acetone, flow rate: 1 ml/min, column temperature: 40°C) to give 5 (19.0 mg, 14.5%) as yellow needles, mp 126-128°C (after recrystallization from methanol 
1,8-Di-O-dodecylaloe-emodin (7)
The general alkylation of 3 (100 mg, 0.37 mmol) with dodecyl iodide (550 mg, 1.9 mmol) gave 7 (90.0 mg, 40.0%) as yellow needles, mp 110-112°C (after recrystallization from acetone 15-Bromochrysophanol (9) To a slolution of aloe-emodin 3 (500 mg, 1.85 mmol) in THF (100 ml), PPh 3 (2.65 g, 10.1 mmol) and CBr 4 (3.35 g, 10.1 mmol) were added and stirred at room temperature for 2 h. The reaction mixture was filtered and the filtrate was evaporated to give a residue that was subjected to column chromatography (toluene) to obtain compound 9 (505 mg, 81.9%) as a yellow solid (mp 221-223°C 15-Diethylaminochrysophanol (10) To a solution of 9 (100 mg, 0.3 mmol) in DMF (10 ml), diethylamine (250 ml, 2.4 mmol) was added and stirred at room temperature for 12 h. The reaction mixture was poured into ice-cold water (50 ml), and then extracted with AcOEt (50 mlϫ3). The extracts were successively washed with 10% NaHCO 3 , and water, and then dried over absolute MgSO 4 and filtered. The filtrate was evaporated to give a residue that was subjected to preparative TLC (5% MeOH in CH 2 Cl 2 ) to obtain compound 10 (46.9 mg, 48.3% yield, mp 97-99°C after recrystallization form acetone Table 4 .
15-(1H-Imidazol-1-yl)chrysophanol (14)
The general amination of 9 (100 mg, 0. Table 4 .
1,8-Di-O-hexyl-15-O-tosylaloe-emodin (16)
To a solution of 6 (440 mg, 1.0 mmol) in ether (100 ml), tosylchloride (1.0 g, 5.3 mmol) and KOH (1.27 g, 22.6 mmol) were added and stirred at room temperature for 1 h. The reaction mixture was poured into ice-cold water (100 ml) and extracted with AcOEt (100 mlϫ3). The extracts were successively washed with 5% HCl, 10% NaHCO 3 , brine and water, and then dried over absolute MgSO 4 and filtered. The filtrate was evaporated to give a residue that was subjected to column chromatography (a gradient of 0-1% acetone in toluene) to obtain compound 16 (316 mg, 53.3%). 
1,8-Di-O-hexyl-15-iodochrysophanol (15)
To a solution of compound 16 (1.0 g, 1.7 mmol) in 3-pentanone (120 ml), NaI (500 mg, 3.4 mmol) was added and stirred at room temperature for 1 h. The reaction mixture was poured into ice-cold water (100 ml) and extracted with AcOEt (100 mlϫ3). The extracts were successively washed with 10% Na 2 S 2 O 3 , brine and water, and then dried over absolute Na 2 SO 4 and filtered. The filtrate was evaporated to give a residue that was subjected to column chromatography (toluene) to obtain compound 15 (520 mg, 55.8%) as a yellow solid (mp 145-147°C). 9 (C-9), 181.5 (C-10), 159.3 (C-8) , 158.9 (C-1), 145.2 (C-3), 135.2 (C-14), 134.7 (C-11), 133.5 (C-6), 124.5 (C-12), 123.9 (C-13), 119.6 (C-7), 119.3 (C-5), 118.8 (C-2), 118.6 (C-4), 69.9 and 69.8 (1-, 8-OCH 2 ), 31.5 (CH 2 ϫ2), 29.7 (C-15), 29.0 (CH 2 ϫ2), 25.5 (CH 2 ϫ2), 22.6 (CH 2 ϫ2), 14.0 (CH 3 ϫ2).
15-Diethylamino-1,8-di-O-hexylchrysophanol (17)
To a solution of 15 (100 mg, 0.18 mmol) in DMF (10 ml), diethylamine (110 ml, 1.1 mmol) was added and stirred at room temperature for 4 h. The reaction mixture was poured into ice-cold water (50 ml), and then extracted with AcOEt (30 mlϫ3). The extracts were successively washed with 10% NaHCO 3 , and water, and then dried over absolute MgSO 4 and filtered. The filtrate was evaporated to give a residue that was subjected to column chromatography (a gradient of 0-3% MeOH in CHCl 3 ) to obtain compound 17 (51. 5 Table 4 .
15-Thiocyanochrysophanol (22)
A solution of bromide 9 (50 mg, 0.15 mmol) in absolute DMF (10 ml) was added with KSCN (58 mg, 0.6 mmol) and stirred at 65°C for 1 h. The reaction mixture was poured into ice-cold water (20 ml) and extracted with CH 2 Cl 2 (20 mlϫ3). The extracts were washed successively with brine and water, and then dried over absolute Na 2 SO 4 and filtered. The filtrate was evaporated to give a residue that was subjected to column chromatography (a gradient of 0-2% AcOEt in toluene) to obtain compound 22 (25 mg, 53.5%) as solid (mp 192-194°C 
15-Selenocyanochrysophanol (23)
A solution of bromide 9 (50 mg, 0.15 mmol) in absolute DMF (10 ml) was added with KSeCN (87 mg, 0.6 mmol) and stirred at room temperature for 1 h. The reaction mixture was poured into ice-cold water (20 ml) and extracted with CH 2 Cl 2 (20 mlϫ3). The extracts were washed successively with brine and water, and then dried over absolute Na 2 SO 4 and filtered. The filtrate was evaporated to give a residue which was subjected to column chromatography (a gradient of 0-2% AcOEt in toluene) to obtain compound 23 (35 mg, 65.1%) as a yellow solid (mp 178-181°C Hep G2 cells were cultured in DMEM. Each medium was supplemented with 10% FBS and a penicillin-streptomycin mixture at 37°C in a humidified atmosphere containing 5% CO 2 in air. Assay Procedure Aliquots (200 ml) of 5ϫ10 3 cells per ml of HCT 116 and Hep G2 cells were seeded in 96 well flat-bottomed plates (Microtest TM Tissue Culture Plate, 96 Well, Flat Bottom with Low Evaporation Ltd., Falcon, NJ, U.S.A.), and they were incubated in a medium containing 10% FBS and a penicillin-streptomycin mixture at 37°C in a humidified atmosphere of 5% CO 2 for 24 h. The test drugs were dissolved in dimethyl sulfoxide (DMSO). The incubation medium was replaced with each test medium giving a final concentration of 0.1-500 mmol/l of test compounds and no drug in 2 ml DMSO over 2 d. The ability of the drug to inhibit cellular growth was determined by performing the MTT assay.
15) The cytotoxic effects of the test drugs were determined as previously described. 1) Each experiment was performed in duplicate wells, and all the experiments involving a control (DMSO only) and the drug treatments were performed separately three to five times. The data represent meanϮS.D. values.
